1057 studies found for:
multiple sclerosis.
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Active, not recruiting |
Exploratory Study to Assess the Effect of Fampridine on Walking Ability and Balance in Patients With Multiple Sclerosis.
|
||||
| 22 | Recruiting |
Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.
|
||||
| 23 | Enrolling by invitation |
Progression of Cognitive and Physical Symptoms in Multiple Sclerosis
|
||||
| 24 | Unknown † |
Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS)
|
||||
| 25 | Completed |
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
|
||||
| 26 | Unknown † |
A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
|
||||
| 27 | Unknown † |
Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis
|
||||
| 28 | Recruiting |
Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis
|
||||
| 29 |
Completed
Has Results |
A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis
|
||||
| 30 |
Completed
Has Results |
A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis
|
||||
| 31 | Recruiting |
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
|
||||
| 32 |
Completed
Has Results |
A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
|
||||
| 33 | Completed |
Study Assessing the Interaction of Pantoprazole With Cladribine in Subjects With Multiple Sclerosis
|
||||
| 34 | Completed |
Study Evaluating CCI-779 in Relapsing Multiple Sclerosis
|
||||
| 35 | Completed |
Depression and Fatigue in MS Patients Treated With Betaferon.
|
||||
| 36 | Completed |
Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b
|
||||
| 37 | Terminated |
MUltiple Sclerosis and Extract of Cannabis (MUSEC) Study
|
||||
| 38 | Terminated |
Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)
|
||||
| 39 | Completed |
Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis
|
||||
| 40 | Recruiting |
Complementary and Alternative Care in Multiple Sclerosis
|
† Indicates status has not been verified in more than two years

